January 15, 2021January 13, 2021
New Year, Same Old COVID-19 Fears
Columns, Courage to Care - a column by Christie Patient
For me, the scariest part of the pandemic has been imagining one of my loved ones developing a severe ... Read more
January 15, 2021January 15, 2021
United Therapeutics Sponsors PFF Registry
News
The Pulmonary Fibrosis Foundation (PFF) announced that United Therapeutics will sponsor the PFF Registry. The Registry is a research ... Read more
January 14, 2021January 12, 2021
PTSD Is Common in Chronically Ill Patients. Here’s How I Address It
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
As a columnist for BioNews, I try to write about a variety of topics pertaining to patients living with ... Read more
January 13, 2021January 8, 2021
Transplant in the Time of Coronavirus
Columns, The Emotional Support Daughter – a Column by Emma Schmitz
On a beautiful Thursday afternoon late last May, my partner and I took the dogs swimming at our secret ... Read more
January 13, 2021January 13, 2021
Fatigue Weights on IPF Patients and Tends to Worsen Over Time, Study Finds
News
Fatigue can be a significant burden for people with idiopathic pulmonary fibrosis (IPF), and tends to worsen as ... Read more
January 12, 2021January 12, 2021
NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum
News, syndicated
The National Organization for Rare Disorders (NORD) is seeking individuals willing to share real-life experiences with rare diseases to ... Read more
January 12, 2021January 12, 2021
First Patient Enrolls in Study of NAC for Targeted Treatment in IPF
News
The first patient has enrolled in a Phase 3 clinical trial testing whether N-acetyl cysteine (NAC), an antioxidant, can ... Read more
January 11, 2021January 11, 2021
Endeavor Raises $62M for New Trials for Taladegib IPF Therapy
News
Endeavor BioMedicines has raised $62 million in series A funding to support the launch of two Phase 2 trials evaluating ... Read more
January 7, 2021January 5, 2021
These Resources Can Help Reduce Anxiety During the Pandemic
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
Many have noted that the recent holiday season was difficult due to the pandemic, as large family gatherings were ... Read more
January 6, 2021January 6, 2021
Dosing Begins in 2nd Phase 3 Trial of Antibody Treatment for IPF
News
Dosing has begun in a second Phase 3 trial testing FibroGen’s investigational antibody pamrevlumab in treating idiopathic pulmonary fibrosis (IPF). Still ... Read more
January 5, 2021January 5, 2021
MBD2 Protein Eyed as Potential Therapeutic Target for PF
News
Suppressing MBD2, a DNA-binding protein, reduced the number of pro-fibrotic macrophages — a type of immune cell involved in ... Read more
January 4, 2021January 4, 2021
Top 10 Pulmonary Fibrosis Stories of 2020
News
During 2020, Pulmonary Fibrosis News held to its mission of providing daily coverage of breakthrough discoveries, promising therapies, ... Read more

January 15, 2021January 13, 2021

New Year, Same Old COVID-19 Fears

Columns, Courage to Care - a column by Christie Patient

For me, the scariest part of the pandemic has been imagining one of my loved ones developing a severe case of COVID-19. Relatable statement, I know. But I don’t ... Read more

January 15, 2021January 15, 2021

United Therapeutics Sponsors PFF Registry

News

The Pulmonary Fibrosis Foundation (PFF) announced that United Therapeutics will sponsor the PFF Registry. The Registry is a research resource that tracks clinical data, samples, and patient-reported outcomes from people ... Read more

January 14, 2021January 12, 2021

PTSD Is Common in Chronically Ill Patients. Here’s How I Address It

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

As a columnist for BioNews, I try to write about a variety of topics pertaining to patients living with idiopathic pulmonary fibrosis (IPF), even those that are taboo or ... Read more

January 13, 2021January 8, 2021

Transplant in the Time of Coronavirus

Columns, The Emotional Support Daughter – a Column by Emma Schmitz

On a beautiful Thursday afternoon late last May, my partner and I took the dogs swimming at our secret spot at a nearby reservoir. A sailboat gliding across the ... Read more

January 13, 2021January 13, 2021

Fatigue Weights on IPF Patients and Tends to Worsen Over Time, Study Finds

News

Fatigue can be a significant burden for people with idiopathic pulmonary fibrosis (IPF), and tends to worsen as the disease progresses or, at best, stay “relatively” stable, a study ... Read more

January 12, 2021January 12, 2021

NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum

News, syndicated

The National Organization for Rare Disorders (NORD) is seeking individuals willing to share real-life experiences with rare diseases to speak at its upcoming virtual Living Rare, Living Stronger NORD ... Read more

January 12, 2021January 12, 2021

First Patient Enrolls in Study of NAC for Targeted Treatment in IPF

News

The first patient has enrolled in a Phase 3 clinical trial testing whether N-acetyl cysteine (NAC), an antioxidant, can be a targeted treatment for a subset of idiopathic pulmonary ... Read more

January 11, 2021January 11, 2021

Endeavor Raises $62M for New Trials for Taladegib IPF Therapy

News

Endeavor BioMedicines has raised $62 million in series A funding to support the launch of two Phase 2 trials evaluating taladegib (ENV-101), its investigational candidate for the treatment of idiopathic ... Read more

January 7, 2021January 5, 2021

These Resources Can Help Reduce Anxiety During the Pandemic

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

Many have noted that the recent holiday season was difficult due to the pandemic, as large family gatherings were discouraged. In some places, Christmas was canceled altogether. Two years ... Read more

January 6, 2021January 6, 2021

Dosing Begins in 2nd Phase 3 Trial of Antibody Treatment for IPF

News

Dosing has begun in a second Phase 3 trial testing FibroGen’s investigational antibody pamrevlumab in treating idiopathic pulmonary fibrosis (IPF). Still recruiting eligible patients at sites in three European countries — Georgia, ... Read more

January 5, 2021January 5, 2021

MBD2 Protein Eyed as Potential Therapeutic Target for PF

News

Suppressing MBD2, a DNA-binding protein, reduced the number of pro-fibrotic macrophages — a type of immune cell involved in pulmonary fibrosis (PF) progression — and lessened lung injury and ... Read more

January 4, 2021January 4, 2021